| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 113402-31-6 | 4,4',4''-亞甲基三苯甲腈 | 4,4',4''-Methylidenetrisbenzonitrile; 4,4’,4’’-METHYLIDENETRISBENZONITRILE; 4,4’,4 -METHYLIDENETRISBENZONITRILE(ImpuriTY OF LETROZOLE); 4,44methyledenetrisbenzonitrile; ImpurityofLetrozole; 4,4’,4”-Methyledenetrisbenzonitrile ( Impurity of Letrozole ) |  | C22H13N3 | 詳情 | 供應(yīng)商 |
| 868754-42-1 | Benzenepropanoic acid,4-[2-(5-ethyl-2-pyridinyl)ethoxy]-, ethyl ester; 4-[2-(5-Ethyl-2-pyridinyl)ethoxy]benzenepropanoic Acid Ethyl Ester(Pioglitazone Impurity); 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-3-[2-(5-ethyl-2-pyridinyl)ethyl]-2,4-thiazolidinedione; N-[Ethyl-(2-pyridyl-5-ethyl) Pioglitazone(Pioglitazone Impurity) |  | C20H25NO3 | 詳情 | 供應(yīng)商 | |
| 74663-48-2 | Phenol,2-(1-methylethyl)-6-propyl-; 2-(1-Methylethyl)-6-propylphenol; 2-Isopropyl-6-propylphenol (Propofol Impurity O); Propofol Impurity O |  | C12H18O | 詳情 | 供應(yīng)商 | |
| 149874-91-9 | 1H-Inden-1-one,2,3-dihydro-5,6-dimethoxy-2-(4-piperidinylmethylene)-; 5,6-Dimethoxy-2-(4-piperidinyl)methyl-indan-1-one (Donepezil Impurity) |  | C17H21NO3 | 詳情 | 供應(yīng)商 | |
| 881399-30-0 | 2H-1,2-Benzothiazine-3-carboxamide,N-ethyl-4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide; Amido Ethyl Meloxicam (Meloxicam Impurity) |  | C16H17N3O4S2 | 詳情 | 供應(yīng)商 | |
| 176220-84-1 | 2,2`-雙納美芬 | 2,2'-Bisnalmefene; (5a)-(5'a)-17,17'-Bis(cyclopropylmethyl)-4,5:4',5'-diepoxy-6,6'-bis(methylene)-[2,2'-bimorphinan]-3,3',14,14'-tetrol; 2,2'-Bis(6-deoxo-6-methylenenaltrexone; 2,2'-Bisnalmefene; 2,2'-Bisnalmefene (Nalmefene Impurity); Nalmefene Impurity | 無(wú) | C42H48N2O6 | 詳情 | 供應(yīng)商 |
| 50725-24-1 | D-Streptamine, o-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-o-(6-amino-6-deoxy-alpha-D-glucopyrano; Brn 1445424; D-Streptamine, o-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-o-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N(sup 3)-(4-amino-2-hydroxybutyryl)-2-deoxy-; 3-(L-4-amino-2-hydroxy-butyryl)kanamycin A (Amikacin Impurity A) | 無(wú) | 詳情 | 供應(yīng)商 | ||
| 503834-19-3 | (4-Carboxy-3-ethoxy)phenyl Acetic Acid (Repaglinide Impurity) |  | C11H12O5 | 詳情 | 供應(yīng)商 | |
| 127472-42-8 | GRANISETRON ImpuriTY A; GRANISETRON ImpuriTY A; 1-Desmethyl 2-Methyl Granisetron (Granisetron Impurity A); endo-N-(9-Methyl-9-Azabicyclo[3.3.1]non-3-yl)-2-methyl-2H-indazole-3-carboxamide |  | C18H24N4O | 詳情 | 供應(yīng)商 | |
| 133330-60-6 | 4,8-Dichloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-β]pyridin-11-one (Loratadine Impurity); 4,8-Dichloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-β]pyridin-11-one (Loratadine Impurity); Loratadine Impurity; 4,8-Dichloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one(Loratadine Impurity) |  | C22H23ClN2O2 | 詳情 | 供應(yīng)商 | |
| 53949-53-4 | 1-羥基異丁基苯基-1'-甲基丙酸 | Benzeneacetic acid, 4-(1-hydroxy-2-methylpropyl)--alpha--methyl- (9CI); Benzeneacetic acid, 4-(1-hydroxy-2-methylpropyl)--alpha--methyl- (9CI); 1-Hydroxy Ibuprofen (Ibuprofen Impurity L)(Mixture of Diastereomers); 2-[4'-(1-Hydroxy-2-methylpropyl)phenyl]propionic Acid; 4-(1-Hydroxy-2-methylpropyl)-a-methylbenzeneacetic Acid |  | C13H18O3 | 詳情 | 供應(yīng)商 |
| 949096-01-9 | 4-[3-(甲氨基)-1-(2 -噻吩)丙基]-1-萘酚氫溴酸 | 4-[3-(Methylamino)-1-(2-thienyl)propyl]-; 4-[3-(Methylamino)-1-(2-thienyl)propyl]-; 4-[3-(Methylamino)-1-(2-thienyl)propyl]-1-naphthalenol Hydrobromide (Duloxetine Impurity) |  | C18H20BrNOS | 詳情 | 供應(yīng)商 |
| 72810-61-8 | 4-(3-Methylphenyl)-2H-pyrido[4,3-e]-1,2,4-thiadiazin-3(4H)-one 1,1-Dioxide; 4-(3-Methylphenyl)-2H-pyrido[4,3-e]-1,2,4-thiadiazin-3(4H)-one 1,1-Dioxide; 4-(3-Methylphenyl)-2H-pyrido[4,3-e]-1,2,4-thiadiazin-3(4H)-one 1,1-Dioxide (Torsemide Impurity) |  | C13H11N3O3S | 詳情 | 供應(yīng)商 | |
| 147770-06-7 | (S)-瑞格列奈乙基酯 | (+)-2-Ethoxy-4-(N-3-Methyl-1(S)-(2-(1-Piperidinyl)Phenyl)-Butyl)Carbamoylmethyl); (+)-2-Ethoxy-4-(N-3-Methyl-1(S)-(2-(1-Piperidinyl)Phenyl)-Butyl)Carbamoylmethyl); (+)-2-ETHOXY-4-(N-3-METHYL-1(S)-(2-(1-PEPERIDINYL)PHENYL)-BUTYL)CARBAMOYLMETHYL) BENZOIC ACID; (S)-Ethyl 2-ethoxy-4-[[[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]amino]carbonyl]methyl]benzoate; (S)-Repaglinide Ethyl Ether (Repaglinide Impurity); 2-Ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic Acid Ethyl Ester; (S)-Repaglinide Ethyl Ester (Repaglinide Impurity) |  | C29H40N2O4 | 詳情 | 供應(yīng)商 |
| 121679-20-7 | 3,4-Dihydro Naratriptan (Naratriptan Impurity B); 3,4-Dihydro Naratriptan (Naratriptan Impurity B); 3,4-Dihydro Naratriptan |  | C17H23N3O2S | 詳情 | 供應(yīng)商 | |
| 201166-22-5 | 2,2-二甲基-4-異丙基-1,3-苯并二惡茂 | 2,2-Dimethyl-4-isopropyl-1,3-benzodioxole (Propofol Impurity L); 2,2-Dimethyl-4-(1-methylethyl)-1,3-benzodioxole; 2,2-Dimethyl-4-isopropyl-1,3-benzodioxole (Propofol Impurity L); Propofol Impurity L; 2,2-Dimethyl-4-isopropyl-1,3-benzodioxole; 1,3-Benzodioxole, 2,2-dimethyl-4-(1-methylethyl)- |  | C12H16O2 | 詳情 | 供應(yīng)商 |
| 153381-68-1 | 7-表多西他賽 | 7-Epi-docetaxel (Docetaxel Impurity C); (2b,5b,7a,10b,13a)-4-Acetoxy-13-(((2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl)oxy)-1,7,10-trihydroxy- 9-oxo-5,20-epoxytax-11-en-2-yl Benzoate; 7-Epidocetaxel; 7-Epi-docetaxel (Docetaxel Impurity C); 7-Epitaxotere; Docetaxel Impurity C | 無(wú) | C43H53NO14 | 詳情 | 供應(yīng)商 |
| 162784-72-7 | 7-Epi-10-oxo-docetaxel (Docetaxel Impurity D); (2b,5b,7a,13a)-4-Acetoxy-13-(((2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl)oxy)-1,7-dihydroxy- 9,10-dioxo-5,20-epoxytax-11-en-2-yl Benzoate; 7-Epi-10-oxo-docetaxel (Docetaxel Impurity D); Docetaxel Impurity D; 7-Epi-10-oxo Docetaxel | 無(wú) | C43H51NO14 | 詳情 | 供應(yīng)商 | |
| 130793-28-1 | (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity); Orlistat Impurity; (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity) |  | C29H55NO6 | 詳情 | 供應(yīng)商 | |
| 191546-97-1 | 10-Oxo Mirtazapine (Mirtazapine Impurity F) | 無(wú) | 詳情 | 供應(yīng)商 | ||